Cape Ann Savings Bank Biogen Inc. Transaction History

Cape Ann Savings Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 22, 2021	SELL	$282.99 - $369.05 $636,444 - $829,993	-2,249 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$259.0 - $414.71 $180,782 - $289,467	-698 Reduced 23.69%	2,249 $778,000
Q1 2021 May 25, 2021	SELL	$242.95 - $284.63 $13,362 - $15,654	-55 Reduced 1.83%	2,947 $824,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $50,087 - $75,393	-212 Reduced 6.6%	3,002 $735,000
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $305,994 - $405,236	1,183 Added 58.25%	3,214 $860,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $114,156 - $128,037	525 Added 34.86%	2,031 $472,000
Q2 2019 Jul 31, 2019	BUY	$219.29 - $241.72 $11,403 - $12,569	52 Added 3.58%	1,506 $353,000
Q4 2018 Feb 15, 2019	BUY	$278.5 - $352.75 $6,962 - $8,818	25 Added 1.75%	1,454 $437,000
Q3 2018 Oct 23, 2018	BUY	$293.51 - $383.83 $4,402 - $5,757	15 Added 1.06%	1,429 $505,000
Q3 2018 Oct 22, 2018	BUY	$293.51 - $383.83 $415,023 - $542,735	1,414 New	1,414 $506,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cape Ann Savings Bank, based on Form 13F filings with the SEC.

Stay updated on Cape Ann Savings Bank with notifications on news.